Mouse SARS-CoV2 S-Protein ACE2 Binding Domain Monoclonal Antibody | anti-SARS-CoV2S antibody

SARS-CoV2 S-Protein ACE2 Binding Domain

Cat. Num. AAA76640

• Applications: Immunofluorescence, Western Blot, Immunocytochemistry
• Synonyms: SARS-CoV2 S-Protein ACE2 Binding Domain, Antibody; SARS-CoV2 S-Protein ACE2 Binding Domain; anti-SARS-CoV2S antibody

• Host: Mouse
• Clonality: Monoclonal
• Isotype: Mouse IgG
• Form/Format: Affinity Purified antibody; Liquid. Purified antibody at 1mg/mL in 50% PBS, 50% glycerol plus 5mM NaN3

• Applicable Applications for anti-SARS-CoV2S antibody: IF (Immunofluorescence), WB (Western Blot), ICC (Immunocytochemistry)
• Immunogen: Recombinant SARS-CoV2 S-Protein ACE2 binding domain expressed in and purified from E Coli
• Preparation and Storage: Antibody can also be aliquotted and stored frozen at -20 degree C in a manual defrost freezer for six months without detectable loss of activity. The antibody is stableat 2-8 degree C for 1 year. Avoid repeated freeze-thaw cycles.

WB (Western Blot)

(Western blot analysis of HEK293 cell lysates using mouse mAb to SARS-CoV2-bd protein dilution 1:3,000 in green: [1] protein standard, [2] non-transfected cells, [3] cells transfected with pCI-Neo-Mod containing the SARS-CoV2-bd cDNA, and [4] cells transfected with pCI-Neo-GFP vector expression construct containing containing the SARS-CoV2-bd cDNA.)

IF (Immunofluorescence)

(Immunofluorescent analysis of HEK293 cells transfected with pCI-Neo-Mod vector (5) including SARS-CoV2-bd cDNA and stained with mouse mAb to SARS-CoV2-bd, MO22198, dilution 1:1,000, in red. The blue is Hoechst staining of nuclear DNA. The antibody reveals expression of SARS-CoV2-bd protein only in transfected cells. DAPI reveals the nuclear DNA of both transfected and non-transfected cells.)

Related Product Information for anti-SARS-CoV2S antibody

In late 2019 a novel infectious disease was discovered in Wuhan, China which was quickly recognized to be caused by a previously unknown RNA coronavirus. The virus was very rapidly isolated, the full RNA sequence determined and put on-line on the 10th of January 2020. The sequence revealed that the virus was most closely related to certain bat coronaviruses and the severe acute respiratory syndrome (SARS) coronavirus. Immediately biotechnology companies and research institutes used the RNA sequence information to generate vaccine candidates. The SARS virus was known to enter and infect human cells by means of the so-called spike or S-protein which binds to the extracellular domain of the angiotensin converting enzyme 2 (ACE2) protein, which is then internalized bringing the virus into the cell. Cryoelectron microscopy and binding studies quickly determined that the S-protein of SARS-CoV2 is structurally similar to to that of the SARS virus and also binds to the ACE2 receptor, albeit with higher affinity than the S-protein of SARS.

NCBI and Uniprot Product Information

• UniProt Accession #: P0DTC2